- $2.27m
- -$2.11m
- $2.93m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.59 | ||
| Price to Tang. Book | 0.59 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.66 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -249.17% | ||
| Return on Equity | -393.98% | ||
| Operating Margin | -446.39% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.05 | 0.04 | 0.16 | 0.69 | 2.93 | 4.55 | 8.99 | 171.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tenon Medical, Inc. is a medical device company. The Company has developed the Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. The Catamaran System is designed specially to resist vertical shear and rotation of the joint in which it was implanted, helping stabilize the joint in preparation for eventual fusion. The Company has also developed a proprietary two-dimensional (2D) placement protocol as well as a protocol for three-dimensional (3D) navigation utilizing the latest techniques in spine surgery.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- June 19th, 2012
- Public Since
- April 27th, 2022
- No. of Shareholders
- 64
- No. of Employees
- 21
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 3,729,474
- Address
- 104 Cooper Ct., Suite 6, LOS GATOS, 95032
- Web
- https://www.tenonmed.com/
- Phone
- +1 4086495760
- Contact
- Shannon Devine
- Auditors
- Haskell & White LLP
Upcoming Events for TNON
Q2 2024 Tenon Medical Inc Earnings Release
Q3 2024 Tenon Medical Inc Earnings Release
Similar to TNON
Accelerate Diagnostics
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
Agendia NV
NASDAQ Capital Market
FAQ
What is the Tenon Medical share price?
As of Today at 23:42 UTC, shares in Tenon Medical are trading at $0.57. This share price information is delayed by 15 minutes.
How has the Tenon Medical share price performed this year?
Shares in Tenon Medical last closed at $0.57 and the price had moved by -80.85% over the past 365 days. In terms of relative price strength the Tenon Medical share price has underperformed the S&P500 Index by -84.76% over the past year.
What are the analyst and broker recommendations for Tenon Medical?
The overall consensus recommendation for Tenon Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Tenon Medical dividend yield?
Tenon Medical does not currently pay a dividend.
Does Tenon Medical pay a dividend?
Tenon Medical does not currently pay a dividend.
When does Tenon Medical next pay dividends?
Tenon Medical does not currently pay a dividend.
How do I buy Tenon Medical shares?
To buy shares in Tenon Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Tenon Medical?
As of the previous close price of $0.57, shares in Tenon Medical had a market capitalisation of $2.13m.
Where are Tenon Medical shares listed?
Here are the trading details for Tenon Medical:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: TNON
What kind of share is Tenon Medical?
Based on an overall assessment of its quality, value and momentum Tenon Medical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Tenon Medical share price forecast for 2024?
The analyst consensus target price for shares in Tenon Medical is $3.50. That is 514.04% above the last closing price of $0.57.
Analysts covering Tenon Medical currently have a consensus Earnings Per Share (EPS) forecast of -$4.14 for the next financial year.
What is the trend in the Tenon Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tenon Medical. Over the past six months, its share price has underperformed the S&P500 Index by -72.48%.
As of the last closing price of $0.57, shares in Tenon Medical were trading -56.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Tenon Medical PE Ratio?
The Tenon Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.57.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Tenon Medical?
We do not have data on Tenon Medical's directors